Manufacturing cell therapeutics through GMP-grade protein services

With the rapid development of novel biological products such as cell therapy products, the demand for the production of raw materials is constantly on the rise. Among them, the quality, performance, consistency and safety of raw materials for cell culture have increasingly become an industry focus.

Manufacturing cell therapeutics through GMP-grade protein services

Image Credit: ACROBiosystems

With more than ten years of experience in developing and manufacturing proteins, ACROBiosystems has developed more than 5,000 recombinant protein products.

To better meet the needs of cell therapy products' development stages and applications and to comprehensively accelerate the research and development process, ACROBiosystems has launched its custom GMP-grade protein services.

ACROBiosystems strictly complies with regulations surrounding cell therapy raw materials and excipients, relying on GMP facilities through advanced protein expression technology and comprehensive quality management system and quality controls.

This is done to ensure consistency between batches and to completely control the contamination caused by viruses, mycoplasma, bacteria, endotoxins, and other external factors.

To minimize the risk of external contamination, each stage is automated or executed in a sterile environment. Equipment and media used in production and purification processes have been verified to be animal-free.

ACROBiosystems offers two distinct developmental procedures to enable a smooth transition from the preclinical to the clinical phase: converting their non-GMP protein products to GMP or creating a unique, GMP-grade protein product from scratch.

GMP-grade protein products perform similarly to their non-GMP-grade protein counterpart and employ the same clone, sequence, and expression method. Users can save time and money and meet deadlines by using non-GMP proteins (Premium or RUO reagents).

Moving further down the clinical phases, the products from ACROBiosystems are prepared to scale up and meet user expectations through clinical research and beyond. Moreover, ACROBiosystems can offer bespoke development services from scratch and guarantee that its products are structurally sound and approved for the production of cellular therapies.

Various expression systems, purification methods, and protein tags/labels can be chosen to improve the therapy’s efficacy.

Manufacturing cell therapeutics through GMP-grade protein services

Image Credit: ACROBiosystems

The custom GMP-grade protein services offered by ACROBiosystems are intended to deliver top-notch raw materials without impeding customers’ product development processes and provide comprehensive assistance for clinical trials.

About ACROBiosystems

ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Their mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. They supply life science tools designed to be used in discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, ACROBiosystems delivers solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. ACROBiosystems empower scientists and engineers dedicated towards innovation to simplify and accelerate the development of new, better, and more affordable medicine.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: Jan 27, 2024 at 3:17 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    ACROBiosystems. (2024, January 27). Manufacturing cell therapeutics through GMP-grade protein services. News-Medical. Retrieved on May 25, 2024 from https://www.news-medical.net/whitepaper/20230301/Manufacturing-cell-therapeutics-through-GMP-grade-protein-services.aspx.

  • MLA

    ACROBiosystems. "Manufacturing cell therapeutics through GMP-grade protein services". News-Medical. 25 May 2024. <https://www.news-medical.net/whitepaper/20230301/Manufacturing-cell-therapeutics-through-GMP-grade-protein-services.aspx>.

  • Chicago

    ACROBiosystems. "Manufacturing cell therapeutics through GMP-grade protein services". News-Medical. https://www.news-medical.net/whitepaper/20230301/Manufacturing-cell-therapeutics-through-GMP-grade-protein-services.aspx. (accessed May 25, 2024).

  • Harvard

    ACROBiosystems. 2024. Manufacturing cell therapeutics through GMP-grade protein services. News-Medical, viewed 25 May 2024, https://www.news-medical.net/whitepaper/20230301/Manufacturing-cell-therapeutics-through-GMP-grade-protein-services.aspx.

Other White Papers by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.